FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904324006> ?p ?o ?g. }

• W2904324006 endingPage "152787" @default.
• W2904324006 startingPage "152787" @default.
• W2904324006 abstract "Elemene injection is an anticancer Chinese patent medicine that is widely used for the treatment of advanced lung cancer. Its active ingredients are β-, γ- and δ-elemene, which are extracted from Curcuma aromatica Salisb. (Curcuma wenyujin Y.H. Chen & C. Ling). To evaluate the effects of Elemene injection as adjunctive treatment to platinum-based chemotherapy (PBC) in patients with stage III/IV non-small cell lung cancer. A systematic review and meta-analysis of randomized clinical trials (RCTs). A systematic review and meta-analysis were conducted following the PRISMA (Preferred Reported Items for Systematic Review and Meta-analysis) guidelines. Analyses were performed using Review Manager 5.3, Comprehensive Meta-Analysis 3.0 and Trial Sequential Analysis software. All RCTs comparing Elemene injection combined with PBC vs. PBC alone were selected and assessed for inclusion. The disease control rate (DCR) was defined as the primary endpoint, and the objective Response rate (ORR), survival rate, quality of life (QOL), cellular immune function and toxicities were the secondary outcomes. 15 RCTs recruiting 1,410 patients with stage III/IV NSCLC were included. The methodological quality of most included trials was low to moderate. Compared with PBC alone, Elemene injection plus PBC can improve DCR (RR = 1.23, 95% CI 1.16 to 1.31, p < 0.00001), ORR (RR = 1.62, 95% CI 1.44 to 1.82, p < 0.00001), 1- and 2-year survival rates (RR = 1.33, 95% CI 1.11 to 1.59, p = 0.002; RR = 1.73, 95% CI 1.21 to 2.46, p = 0.002, respectively), QOL (RR = 1.91, 95% CI 1.58 to 2.32, p < 0.00001), CD4+T cell counts (WMD = 10.43, 95% CI 8.25 to 12.62, p < 0.00001), and the CD4+/CD8+ratio (WMD = 0.78, 95% CI 0.42 to 1.14, p < 0.0001) and can reduce severe toxicities by 58% (RR = 0.42, 95% CI 0.34 to 0.52, p < 0.00001). Elemene injection is a safe and effective adjunctive treatment to platinum-based chemotherapy in patients with stage III/IV NSCLC. Elemene injection can improve clinical efficacy, enhance cellular immune function and alleviate the toxicity of chemotherapy. High-quality RCTs with significant survival outcomes and longer follow-ups are warranted to confirm the results further." @default.
• W2904324006 created "2018-12-22" @default.
• W2904324006 creator A5015970814 @default.
• W2904324006 creator A5021570234 @default.
• W2904324006 creator A5041572932 @default.
• W2904324006 creator A5041694925 @default.
• W2904324006 creator A5078753498 @default.
• W2904324006 creator A5090712009 @default.
• W2904324006 date "2019-06-01" @default.
• W2904324006 modified "2023-10-14" @default.
• W2904324006 title "Elemene injection as adjunctive treatment to platinum-based chemotherapy in patients with stage III/IV non-small cell lung cancer: A meta-analysis following the PRISMA guidelines" @default.
• W2904324006 cites W1505103273 @default.
• W2904324006 cites W1525320991 @default.
• W2904324006 cites W1544583478 @default.
• W2904324006 cites W1964435302 @default.
• W2904324006 cites W1984647853 @default.
• W2904324006 cites W1986215651 @default.
• W2904324006 cites W1996097988 @default.
• W2904324006 cites W2013108722 @default.
• W2904324006 cites W2016285056 @default.
• W2904324006 cites W2027044194 @default.
• W2904324006 cites W2045019712 @default.
• W2904324006 cites W2069033632 @default.
• W2904324006 cites W2073509523 @default.
• W2904324006 cites W2097069128 @default.
• W2904324006 cites W2123477033 @default.
• W2904324006 cites W2130948780 @default.
• W2904324006 cites W2135631135 @default.
• W2904324006 cites W2135989615 @default.
• W2904324006 cites W2138425596 @default.
• W2904324006 cites W2142518692 @default.
• W2904324006 cites W2148257845 @default.
• W2904324006 cites W2156098321 @default.
• W2904324006 cites W2157823046 @default.
• W2904324006 cites W2167805334 @default.
• W2904324006 cites W2175538234 @default.
• W2904324006 cites W2415169211 @default.
• W2904324006 cites W2550108147 @default.
• W2904324006 cites W2617382094 @default.
• W2904324006 cites W2619195667 @default.
• W2904324006 cites W2626942488 @default.
• W2904324006 cites W2731845861 @default.
• W2904324006 cites W2739799978 @default.
• W2904324006 cites W2761398065 @default.
• W2904324006 cites W2763871286 @default.
• W2904324006 cites W2765741129 @default.
• W2904324006 cites W2781525129 @default.
• W2904324006 cites W2796611961 @default.
• W2904324006 cites W2800268853 @default.
• W2904324006 cites W2889646458 @default.
• W2904324006 cites W2896184246 @default.
• W2904324006 cites W2991792334 @default.
• W2904324006 doi "https://doi.org/10.1016/j.phymed.2018.12.010" @default.
• W2904324006 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31005810" @default.
• W2904324006 hasPublicationYear "2019" @default.
• W2904324006 type Work @default.
• W2904324006 sameAs 2904324006 @default.
• W2904324006 citedByCount "54" @default.
• W2904324006 countsByYear W29043240062019 @default.
• W2904324006 countsByYear W29043240062020 @default.
• W2904324006 countsByYear W29043240062021 @default.
• W2904324006 countsByYear W29043240062022 @default.
• W2904324006 countsByYear W29043240062023 @default.
• W2904324006 crossrefType "journal-article" @default.
• W2904324006 hasAuthorship W2904324006A5015970814 @default.
• W2904324006 hasAuthorship W2904324006A5021570234 @default.
• W2904324006 hasAuthorship W2904324006A5041572932 @default.
• W2904324006 hasAuthorship W2904324006A5041694925 @default.
• W2904324006 hasAuthorship W2904324006A5078753498 @default.
• W2904324006 hasAuthorship W2904324006A5090712009 @default.
• W2904324006 hasConcept C121608353 @default.
• W2904324006 hasConcept C126322002 @default.
• W2904324006 hasConcept C141071460 @default.
• W2904324006 hasConcept C143998085 @default.
• W2904324006 hasConcept C168563851 @default.
• W2904324006 hasConcept C185592680 @default.
• W2904324006 hasConcept C190283241 @default.
• W2904324006 hasConcept C203092338 @default.
• W2904324006 hasConcept C2776256026 @default.
• W2904324006 hasConcept C2776694085 @default.
• W2904324006 hasConcept C2781340500 @default.
• W2904324006 hasConcept C530470458 @default.
• W2904324006 hasConcept C55493867 @default.
• W2904324006 hasConcept C71924100 @default.
• W2904324006 hasConcept C95190672 @default.
• W2904324006 hasConceptScore W2904324006C121608353 @default.
• W2904324006 hasConceptScore W2904324006C126322002 @default.
• W2904324006 hasConceptScore W2904324006C141071460 @default.
• W2904324006 hasConceptScore W2904324006C143998085 @default.
• W2904324006 hasConceptScore W2904324006C168563851 @default.
• W2904324006 hasConceptScore W2904324006C185592680 @default.
• W2904324006 hasConceptScore W2904324006C190283241 @default.
• W2904324006 hasConceptScore W2904324006C203092338 @default.
• W2904324006 hasConceptScore W2904324006C2776256026 @default.
• W2904324006 hasConceptScore W2904324006C2776694085 @default.
• W2904324006 hasConceptScore W2904324006C2781340500 @default.
• W2904324006 hasConceptScore W2904324006C530470458 @default.
• W2904324006 hasConceptScore W2904324006C55493867 @default.

• next